Loading the map…
Private limited company registered in London, classed under “Manufacture of basic pharmaceutical products” and 1 other activity.
Headline figures
No figures yet.
This company's accounts are on file with Companies House, but we haven't extracted them yet. Once we do, its net assets, cash, reserves and any disclosed profit will appear here.
Timeline
Checked 2026-11-02
- AccountsFull accounts made up to 31 December 2025
- DirectorsAppointment of Mr Robert William Butler as a director on 16 July 2026
- DirectorsTermination of appointment of Dmytro Oliinyk as a director on 16 July 2026
- AccountsFull accounts made up to 31 December 2024
- DirectorsSecretary's details changed for Mrs Victoria Anne Whyte on 11 September 2024
- AccountsFull accounts made up to 31 December 2023
- DirectorsDirector's details changed for Mr Dmytro Oliinyk on 11 September 2024
- OwnershipChange of details for Glaxosmithkline Finance Plc as a person with significant control on 11 September 2024
- AddressRegistered office address changed from 980 Great West Road Brentford Middlesex TW8 9GS to 79 New Oxford Street London WC1A 1DG on 11 September 2024
- AddressRegister inspection address has been changed
- AccountsFull accounts made up to 31 December 2022
- DirectorsDirector's details changed for Glaxo Group Limited on 6 June 2023
25 earlier
- AccountsFull accounts made up to 31 December 2021
- FilingResolutions (and 8 more like it since 27 October 2009)
- FilingStatement of company's objects
- FilingMemorandum and Articles of Association
- DirectorsAppointment of Mr Dmytro Oliinyk as a director on 19 February 2022
- DirectorsTermination of appointment of Richard John Latchford as a director on 19 February 2022
- AccountsFull accounts made up to 31 December 2020
- DirectorsAppointment of Mr Richard John Latchford as a director on 28 September 2021
- DirectorsTermination of appointment of Erika Patteson-Brent as a director on 17 September 2021
- DirectorsTermination of appointment of Ciara Martha Lynch as a director on 9 November 2020
- AccountsFull accounts made up to 31 December 2019
- DirectorsAppointment of Mrs Erika Patteson-Brent as a director on 25 August 2020
- DirectorsAppointment of Mrs Ciara Martha Lynch as a director on 2 March 2020
- DirectorsTermination of appointment of Adam Walker as a director on 2 March 2020
- AccountsFull accounts made up to 31 December 2018
- DirectorsTermination of appointment of Simon Paul Dingemans as a director on 1 May 2019
- DirectorsAppointment of Mr Adam Walker as a director on 1 May 2019
- AccountsFull accounts made up to 31 December 2017
- AccountsFull accounts made up to 31 December 2016
- AccountsFull accounts made up to 31 December 2015
- AccountsFull accounts made up to 31 December 2014
- AccountsFull accounts made up to 31 December 2013
- DirectorsDirector's details changed for Glaxo Group Limited on 8 March 2013
- AccountsFull accounts made up to 31 December 2012
- DirectorsDirector's details changed for Edinburgh Pharmaceutical Industries Limited on 12 October 2012
- Accounts
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Smithkline Beecham do?
Private limited company registered in London, classed under “Manufacture of basic pharmaceutical products” and 1 other activity.
›How much turnover does Smithkline Beecham make?
Answered in the full report
›Is Smithkline Beecham profitable?
Smithkline Beecham's profit isn't public: small companies may file without a profit and loss account.
›Who runs and owns Smithkline Beecham?
Its directors are Victoria Anne Whyte, Robert William Butler, Edinburgh Pharmaceutical Industries Limited, Glaxo Group Limited. Its owners are shown to subscribers.
›Where is Smithkline Beecham based?
Its registered office is 79 New Oxford Street, London, WC1A 1DG, in London.
›When was Smithkline Beecham founded?
Smithkline Beecham Limited was incorporated on 24 January 1989.
›Is Smithkline Beecham still trading?
The register lists Smithkline Beecham Limited as active.